PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM)

Premelanosome protein (PMEL) is crucial for the formation of melanosomal fibrils through the transition from stage I to stage II melanosomes. It was used as a target antigen in some adoptive T-cell therapy of melanoma. The correlation of PMEL to prognosis and immune cell infiltration level are unkno...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuguang, Chen, Kun, Liu, Huanmei, Jing, Changyou, Zhang, Xinxin, Qu, Chunfeng, Yu, Shengji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225232/
https://www.ncbi.nlm.nih.gov/pubmed/34028390
http://dx.doi.org/10.1097/CJI.0000000000000374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225232/
https://www.ncbi.nlm.nih.gov/pubmed/34028390
http://dx.doi.org/10.1097/CJI.0000000000000374

Ejemplares similares